Clinical Trial Update: Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intratumoral microdialysis to characterize abemaciclib neuropharmacokinetics in diffuse midline glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Midline Glioma
• Glioma

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING